Budpak Feminine Anti-Itch

Product NDC: 27293-022
11-digit product format: 272930022
Labeler code: 27293
Product ID: 27293-022_2723f378-f50f-4606-b0b4-d6b33b7eddf2
Type: HUMAN OTC DRUG
Nonproprietary name: Benzocaine and Resorcinol
Dosage form: CREAM
Route: TOPICAL
Labeler: Budpak Inc.
Application: part348
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2013-06-10
Marketing end: 0000-00-00
Substance: BENZOCAINE; RESORCINOL
Active strength: 0 g/g; g/g
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	27293-022		I	Inactivated by FDA		2026-10-05
excluded package	package	27293-022	27293-022-01	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	27293-022-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	27293-022-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	27293-022-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	27293-022-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	27293-022-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	27293-022-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	27293-022-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	27293-022-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	27293-022-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	27293-022-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	27293-022-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	27293-022-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	27293-022-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	27293-022-01	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	27293-022-01	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	27293-022-01	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	27293-022-01	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	27293-022-01	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	27293-022-01	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	27293-022-01	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	27293-022-01	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
60c52429-fcef-eb54-2387-43bc9e4f296b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
27293-022-01	2020-01-31	C162847	48780-1	9d75b9d0-c23b-f424-e053-dadaa90a57ce	c64ec9ab-e916-4fea-9512-b2ab365e0cdc

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
27293-022-01	Budpak Feminine Anti-Itch	1 in 1 BOX	CREAM	1		1
27293-022-21	Budpak Feminine Anti-Itch	21.2 g in 1 TUBE	CREAM	21.2		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BENZOCAINE	ACTIVE INGREDIENT	U3RSY48JW5	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
RESORCINOL	ACTIVE INGREDIENT	YUL4LO94HK	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
BENZOCAINE	ACTIVE MOIETY	U3RSY48JW5	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
RESORCINOL	ACTIVE MOIETY	YUL4LO94HK	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
CARBOMER HOMOPOLYMER TYPE C	INACTIVE INGREDIENT	4Q93RCW27E	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
CHOLECALCIFEROL	INACTIVE INGREDIENT	1C6V77QF41	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
CORN OIL	INACTIVE INGREDIENT	8470G57WFM	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
ISOPROPYL PALMITATE	INACTIVE INGREDIENT	8CRQ2TH63M	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
PEG-100 STEARATE	INACTIVE INGREDIENT	YD01N1999R	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
SODIUM SULFITE	INACTIVE INGREDIENT	VTK01UQK3G	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
TRISODIUM HEDTA	INACTIVE INGREDIENT	K3E0U7O8KI	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
VITAMIN A PALMITATE	INACTIVE INGREDIENT	1D1K0N0VVC	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
27293-022	BUDPAK FEMININE ANTI-ITCH (BENZOCAINE AND RESORCINOL) CREAM [BUDPAK INC.]	1	Legacy NDC, 2 package rows	20130610_c64ec9ab-e916-4fea-9512-b2ab365e0cdc.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U3RSY48JW5	BENZOCAINE	94-09-7	BENZOCAINE
YUL4LO94HK	RESORCINOL	108-46-3	RESORCINOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
243587	benzocaine 5 % / resorcinol 2 % Vaginal Cream	PSN	c64ec9ab-e916-4fea-9512-b2ab365e0cdc	1
243587	benzocaine 50 MG/ML / resorcinol 20 MG/ML Vaginal Cream	SCD	c64ec9ab-e916-4fea-9512-b2ab365e0cdc	1
243587	benzocaine 5 % / resorcinol 2 % Vaginal Cream	SY	c64ec9ab-e916-4fea-9512-b2ab365e0cdc	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
27293-022-01	27293002201	1 in 1 BOX		Historical
27293-022-21	27293002221	21.2 g in 1 TUBE	21.2 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Budpak Feminine Anti-Itch - Budpak Inc. \| Anicare Pharmaceuticals Pvt. Ltd	Budpak Inc. \| Anicare Pharmaceuticals Pvt. Ltd	2013-06-08	HUMAN OTC DRUG LABEL	1